Esteve Quimica S.A.
USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).
The verdict
According to USPTO PatentsView, Esteve ranks #46,571 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 5 technology areas.
- #46,571
- of 49,997 US assignees by volume
- 10th percentile
- by Innovation Score (22.3/100)
- 13.6
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R46571 · Foreign Corporation #46,571 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #46,571/49,997
- PHOTO-FINISH Essence Method Refine
- CPC-NARROW C07D · 5 areas
- INNOV-THIN 22.3/100
- CLAIMS-RICH 13.6 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Essence Method Refine Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Esteve’s 22.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Esteve
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Esteve Quimica · this assignee 22
Esteve Quimica · this assignee
22 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Esteve's Innovation Score is 22.3/100 (10th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Esteve?
Each dot is one of Esteve’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Esteve’s own 13.6 claims/patent is ABOVE the 13.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Esteve's grants concentrate
Esteve Quimica S.A. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2019. By volume, Esteve sits between Essence Method Refine Co., Ltd. and EuControls, Corp.
Who files at Esteve's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Essence Method Re…
Essence Method Refine Co., Ltd.
5 patents
- Essex Solutions U…
Essex Solutions USA LLC
5 patents
- Essity Hygiene an…
Essity Hygiene and Health AB
5 patents
- Ester Industries
Ester Industries Ltd.
5 patents
- Etavision
EtaVision Inc.
5 patents
- Eterbright Solar
Eterbright Solar Corporation
5 patents
- Eton Pharmaceutic…
Eton Pharmaceuticals, Inc.
5 patents
- Eucontrols
EuControls, Corp
5 patents
- Esteve Quimica ◀
Esteve Quimica S.A.
5 patents
What this shows Esteve holds 5 patents at rank #46,622, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Esteve
By rank, the assignees closest to #46,622 in granted patent volume.
- Essence Method Refine Co., Ltd. #46,618 · 5 patents
- Essex Solutions USA LLC #46,619 · 5 patents
- Essity Hygiene and Health AB #46,620 · 5 patents
- Ester Industries Ltd. #46,621 · 5 patents
- EtaVision Inc. #46,623 · 5 patents
- Eterbright Solar Corporation #46,624 · 5 patents
- Eton Pharmaceuticals, Inc. #46,625 · 5 patents
- EuControls, Corp #46,626 · 5 patents
Leaders in C07D (Heterocyclic Compounds)
Other assignees with the most granted patents in Esteve's primary technology class.
Esteve's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
22 10th percentile higher than 10% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 80.0% |
| 2019 | 1 | 20.0% |
Which technologies does Esteve Quimica S.A. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Esteve Quimica S.A.'s patent record in context - here's where to go next.
- Esteve Quimica S.A.'s lead technology class is C07D (Heterocyclic Compounds), 100% of its portfolio - see every assignee active in that class. Explore C07D
- Ranked #46,571 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Esteve Quimica S.A. against Essence Method Refine Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 22.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.